For example, acute myeloid leukemia (AML), myeloma, and Ewing sarcoma have a substantial percentage of samples with high KIT expression, while chronic lymphoblastic leukemia (CLL) has low mean KIT expression, and no patients with CLL have high KIT expression. This evidence concerns the gene KIT and plasma cell myeloma.